1. Nature研究报道揭示白细胞介素-33 (IL-33)激活天然淋巴细胞 (ILC2s)诱导胰腺癌三级淋巴结构 (TLSs)的形成，为胰腺癌治疗带来新希望。 PDAC肿瘤中的TLS特征相关性（a, 上图）： ...

A study reveals that shape-shifting immune cells, intermediate ILC2s, may contribute to severe asthma and resistance to ...

Innate lymphoid cells (ILCs) are immune cells that belong to the lymphoid lineage but do not express antigen-specific receptors. These cells have important functions in innate immune responses to ...

A Potential Therapeutic Target for Steroid Resistant Asthma,” published in the December 2024 issue of Allergy and Immunology ...

A set of chameleon-like immune cells could be contributing to severe asthma in some patients. Intermediate group 2 innate ...

TLSs serve as the immune system’s on-site responders, forming in chronically inflamed tissues, including tumors, to bolster ...

This may result in the histologic diagnosis of AtLP – that is, lymph nodes with distorted architecture and lymphoid cells with worrisome cytological features – but findings are not sufficient ...

Lymphoid proliferations are traditionally thought to be either benign conditions (reactive hyperplasia and lymphadenitis) or malignant lymphomas. However, not all lymphoid lesions at present can ...

Lifordi Immunotherapeutics, Inc., a biotech company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, today announced the appointment of Matthew W.